CC(=O)C1[C@H](N(C)C)CC2C3CC=C4CC(O)CC[C@]4(C)C3CC[C@@]21C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?